Business
The Incannex (ASX:IHL) share price is surging 7% higher today. Here’s why
The Incannex Healthcare Limited (ASX: IHL) share price has zoomed up today as the company announced positive results in its drug study results.
Shares in the bio tech small cap are currently trading 7.5% higher at 17 cents.
What Incannex does
Incannex is a clinical stage pharmaceutical development company in the cannabis industry. The company utilises medicinal cannabis products and psychedelic therapies for the treatment of obstructive sleep apnoea and traumatic brain injury among other things.
Incannex is pursuing FDA registration, subject to ongoing clinical success, for each product under development.
In addition, the company owns a license to import, export and distribute medicinal cannabis products and has launched a line of…
-
General11 hours agoLiberals go back to basics after crawling to year’s end
-
Business17 hours ago3 of the best ASX ETFs to build significant wealth
-
General17 hours agoTrolls stole Dr Juliet Turner’s joy and in doing so took their own
-
General14 hours agoProtecting victims of explicit AI content online